OMATA教授访谈

帅庭

文章导读：APASL is mainly dealing with liver disease, which is very common in Asia. In that context the treatment of the hepatitis B virus is in full swing now. We are now able to talk about not just suppression of the virus, but how we can eliminate the disease itself.

Masao Omata  University of Tokyo, Japan

Hepatology Digest: As a past president of APASL, what are some of the biggest highlights of this year’s annual APASL meeting?

Prof. Omata: APASL is mainly dealing with liver disease, which is very common in Asia. In that context the treatment of the hepatitis B virus is in full swing now. We are now able to talk about not just suppression of the virus, but how we can eliminate the disease itself
更多精彩内容请点击：http://apasl2009-cn.ihepa.com/17-171-2072.html]

乙Vampire肝

嘻嘻~~谢谢了~~看到~~顶一下~~